Cancer Screening – Victorian Cytology Service – continuation

The Government will spend $41.6 million to extend an agreement with the Victorian Government to continue services delivered by the Victorian Cytology Service (VCS), which supports the National Cervical Screening Program (NCSP).

Page last updated: 09 May 2017

PDF version: Cancer Screening – Victorian Cytology Service – continuation (PDF 122 KB)

Why is this important?

Cervical cancer is the third most commonly diagnosed gynaecological cancer in Australian women.

This measure will ensure the VCS can continue to provide services to the NCSP, including quality and costing reports and supporting the introduction of the new cervical screening test of the NCSP.

Who will benefit?

Women aged 18–74, whose cervical screens are assessed by the VCS without cost, are the main beneficiaries. In particular, the VCS supports nurses and Aboriginal Health Practitioners to collect screens from women who might not otherwise participate in cervical screening.

All women participating in the NCSP also benefit, because of the expertise and reporting provided by the VCS.

General practitioners, cervical cancer advocacy groups and researchers benefit from the publications and expert knowledge produced by the VCS.

How much will this cost?

This measure will cost $41.6 million from 2017–18 to 2020–21.

In this section